MedEdge MEA

MedNet Global Healthcare Solutions LLC has appointed Daniel Whitehead as CEO in the Middle East and North Africa (MENA) region, effective November 2024. MedNet is a fully owned subsidiary of Munich Re, a global leader in reinsurance and integrated risk management solutions. Read More: https://lnkd.in/dn737TVA Commenting on his appointment, Daniel Whitehead said: “I am delighted to be joining MedNet, a renowned leader in healthcare administration in the Middle East. It's an honor to lead such an incredible team, and I’m excited to work together to deliver outstanding value to our partners and clients.” This leadership transition represents a key milestone for MedNet as it continues to expand its operations and deliver client-centric solutions. Daniel’s extensive experience in healthcare and insurance will play a vital role in strengthening MedNet’s offerings and operational excellence across the MENA region. #HealthcareLeadership #MedNet #MENA #InnovationInHealthcare #MedEdgeMEA

BD (Becton, Dickinson and Company), a leading global medical technology company, and Babson Diagnostics, a science-first health care technology company, announced an expansion of fingertip blood collection and testing technologies for use by U.S. health systems and other large provider networks in settings like urgent cares, doctor offices and other ambulatory care settings. Read More: https://lnkd.in/dxXHyWvE "BetterWay and BD MiniDraw™ are defining what's next in health care," said David Stein, Babson's CEO. "BD has been innovating blood collection technology for 75 years and we believe our partnership will deliver a potentially transformative technology to support innovative and patient-focused health care organizations in better reaching and serving patients." #HealthTech #BloodTesting #InnovationInHealthcare #PatientCare #MedEdgeMEA Bridget B. Tom Polen

Siemens Healthineers has concluded the acquisition from Novartis of Advanced Accelerator Applications Molecular Imaging, a European manufacturing and distribution network of diagnostic radiopharmaceuticals for positron emission tomography (PET) scans. The acquired company will be known as Advanced Accelerator Applications, a Siemens Healthineers company. Read More: https://lnkd.in/dRNj__MV “The radiopharmaceutical sector is at an inflection point thanks in large part to innovation in the pharmaceuticals space, with PET serving as a gateway to patient eligibility for many of the new cancer and neurodegenerative-disorder therapies,” said James Williams, head of Molecular Imaging at Siemens Healthineers. “But even the greatest therapy is of no use unless you can get it to patients in time, so we’re excited to be adding the molecular imaging capabilities of Advanced Accelerator Applications, its first-class operations, extensive experience in nuclear medicine, and proven track record.” #SiemensHealthineers #MolecularImaging #PETScans #PETNET #InnovationInHealthcare #MedEdgeMEA Barry Scott

EHSUAE | مؤسسة الإمارات للخدمات الصحية (EHS), represented by Al Amal Psychiatric Hospital, celebrated the winners of the second edition of the Al Amal Award for Scientific Research during a ceremony held at Al Amal Hospital in Dubai. Following the success of the inaugural edition in 2023, this year’s award aimed to foster a comprehensive, evidence-based mental health care ecosystem, strengthened by specialized research and studies. Read More: https://lnkd.in/dNrmX8cC Noor Alsari Almheiri, Director of the Mental Health Department at EHS, emphasized that the award supports the development of mental health research systems and promotes innovation to provide sustainable solutions to societal mental health challenges. She stated, “This initiative aligns with the UAE’s leadership vision to create an environment conducive to scientific research through policies, strategies, and programs aimed at achieving sustainable development.” #MentalHealthResearch #AlAmalAward2024 #InnovationInHealthcare #MedEdgeMEA Dr. Ammar Albanna MD FRCPC

#QatarNationalDay, observed on December 18, commemorates the unification of Qatar in 1878 and celebrates the leadership of Sheikh Jassim Bin Mohammad Bin Thani. This day honors the nation's core values of loyalty, solidarity, and pride, reflecting on its rich heritage and inspiring future growth. 𝗔 𝗱𝗮𝘆 𝗼𝗳 𝗰𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗶𝗻𝗴 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗮𝗻𝗱 𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀! #QatarNationalDay2024 #UnityAndPride #MedEdgeMEA

VectorY Therapeutics, a biotech company developing innovative vectorized antibody therapies for the treatment of neurodegenerative diseases, announces the appointment of Jim Scibetta as Chief Executive Officer. Read More: https://lnkd.in/dsFg5K_k “On behalf of the Board, I’m delighted to welcome Jim as our new CEO. He brings a significant degree of experience, vision and leadership which will play a critical role at this juncture of VectorY’s development as we advance our lead program. Jim’s experience complements and will build on the great progress that Sander and the VectorY team have achieved over the past four years.” said Adam Rosenberg, Chairman of VectorY Therapeutics said #mededgemea #HealthcareLeadership #ALSResearch #BiotechInnovation #NeurodegenerativeDiseases #CorporateLeadership Sander van Deventer

Adagio Medical Inc. announced that founder Olav Bergheim departed as Chief Executive Officer and Chairperson of the Board of Directors of the Company, effective December 13, 2024. Concurrently, the Company announced the appointment of Todd Usen, as Chief Executive Officer and Director of the Company and Orly Mishan, as Chairperson of the Board of Directors, effective December 13, 2024. Mr. Bergheim will serve as an advisor to the Company and will support Mr. Usen with the transition through December 13, 2025 Read More: https://lnkd.in/dXgGcaib “I’m thrilled to join Adagio at this important junction in the Company’s history, supporting initial commercial efforts in Europe, and the FULCRUM-VT trial enrollment in the United States,” said Todd Usen. “With a growing body of evidence demonstrating both the safety and effectiveness of Adagio’s Ultra-Low Temperature Cryoablation technology and marked enthusiasm of users in both Europe and North America, I believe that Adagio’s VT Cryoablation System with vCLAS catheter will become the future standard of care for treatment of patients with ventricular tachycardia.” #mededgemea #HealthcareLeadership #CardiacCare #MedicalDevices #VentricularTachycardia #CorporateLeadership #MedicalInnovation

Having recently signed an agreement to fight rabies in Kenya, particularly Machakos County, Boehringer Ingelheim and Vétérinaires Sans Frontières Germany/ Tierärzte ohne Grenzen (VSF Germany) continue their successful cooperation. The partnership includes vaccination drives, community awareness initiatives, and educational programs in schools. Boehringer Ingelheim is contributing rabies vaccines and funding while VSF Germany leads the program implementation alongside local stakeholders. Read More: https://lnkd.in/dMf_vFT7 "The cooperation with Boehringer Ingelheim is an important milestone for our organization," says Christian Griebenow, CEO of Vétérinaires sans Frontières Germany. "Together, we can make strides towards preventing and controlling rabies in Kenya and raise awareness about this deadly disease. We are grateful for Boehringer Ingelheim’s generous donation and look forward to contributing our many years of experience in implementing animal health programs." #mededgemea #AnimalHealth #RabiesPrevention #GlobalHealth #StopRabies #VaccinationCampaign #PublicHealth Erich Schoett

AnimalhealthEurope has announced the appointment of Pieter-Jan Serreyn as its new Technical Director, succeeding Rick Clayton, who is set to retire at the end of 2024. Read More: https://lnkd.in/dk98Jn7Y Rick Clayton, who has served AnimalhealthEurope for 27 years, will retire in December. Clayton joined the association in 1997 as Technical Manager when it was known as FEDESA, having relocated from the UK to Belgium. Throughout his career, he has played a crucial role in representing manufacturers of animal medicines, vaccines, and health products across Europe. In addition to his work with AnimalhealthEurope, Clayton served as Technical Director for the global association HealthforAnimals, contributing significantly to international efforts to harmonize veterinary product registration requirements. #mededgemea #VeterinaryMedicine #LeadershipChange #AnimalHealth #RegulatoryAffairs #IndustryNews Roxane Roethlisberger Feller 🇨🇭🇪🇺🇧🇪

#BahrainNationalDay, observed on December 16, commemorates the nation’s independence and pays tribute to the late Emir Isa bin Salman Al Khalifa, who ascended to power in 1961. This significant day not only celebrates Bahrain’s rich heritage but also highlights its continued growth, achievements, and dedication to progress. 𝗔 𝗽𝗿𝗼𝘂𝗱 𝗺𝗼𝗺𝗲𝗻𝘁 𝗼𝗳 𝘂𝗻𝗶𝘁𝘆 𝗳𝗼𝗿 𝗕𝗮𝗵𝗿𝗮𝗶𝗻! #BahrainNationalDay2024 #HeritageAndProgress #MedEdgeMEA